8-K: SES AI Receives NYSE Delisting Warning

SES AI Corporation has been notified by the NYSE of its non-compliance with minimum stock price requirements and is working to regain compliance.

Summary

• SES AI Corporation received a notice from the New York Stock Exchange (NYSE) on July 17, 2026, stating it is not in compliance with continued listing standards.
• The non-compliance is due to the average closing price of its Class A common stock being below $1.00 for 30 consecutive trading days.
• The company has a six-month period to regain compliance.
• Compliance can be achieved if the stock price is at least $1.00 on the last trading day of any calendar month during the cure period, and the 30-day average closing price is also at least $1.00.
• Alternatively, if a stock-holder-approved action (like a reverse stock split) is taken, the price condition is deemed cured if it promptly exceeds $1.00 and remains above that level for 30 trading days.
• The company's Class A common stock will continue to trade on the NYSE during this period, provided other listing standards are met.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the NYSE non-compliance notice, indicating potential market concerns about the company's valuation and future prospects.

Positives

• The notice does not result in immediate delisting, and the company's Class A common stock will continue to trade on the NYSE.
• SES AI has a six-month period to regain compliance with the NYSE's continued listing standards.
• The company has outlined specific conditions under which it can regain compliance, including a minimum closing price and average closing price of $1.00.
• The company is actively considering alternatives, including actions requiring stockholder approval, to cure the deficiency.

Negatives

• The company's Class A common stock has an average closing price below $1.00 over 30 consecutive trading days, failing to meet NYSE listing requirements.
• The company is at risk of delisting if it cannot regain compliance within the specified six-month period.

Risks

• Failure to regain compliance with the NYSE continued listing standard within the six-month cure period could lead to delisting.
• The volatility of SES AI's Class A common stock and public warrants could hinder efforts to meet the minimum price requirement.
• Potential need for stockholder approval for actions like a reverse stock split introduces uncertainty and reliance on shareholder support.

Future Outlook

SES AI intends to notify the NYSE of its plan to regain compliance and will consider available alternatives, including actions requiring stockholder approval, to cure the stock price deficiency within the six-month cure period.

Management Comments

• SES AI intends to notify the NYSE of its intent to regain compliance with the NYSE continued listing standard.
• The Company intends to consider available alternatives, if necessary, to cure the stock price non-compliance.

Industry Context

StockSavvy.ai notes that maintaining a listing on major exchanges like the NYSE is crucial for investor confidence and access to capital. Companies facing minimum bid price requirements often explore options such as reverse stock splits, though these can be viewed negatively by the market if not accompanied by fundamental business improvements.

Stakeholder Impact

• Shareholders may experience increased volatility and concern regarding the potential delisting of the company's stock.
• Creditors and potential investors may view the non-compliance as a sign of financial distress, potentially impacting future financing opportunities.

Next Steps

• SES AI will respond to the NYSE within 10 business days of receipt of the notice regarding its intent to cure the deficiency.
• The company will work to ensure its Class A common stock has a closing price of at least $1.00 and an average closing price of at least $1.00 over a 30-day period by the end of any calendar month within the six-month cure period.
• The company may consider actions requiring stockholder approval, such as a reverse stock split, to cure the deficiency.

Key Dates

Recommendation

The filing indicates a significant risk of delisting due to low stock price, which is a negative development. However, the company has a clear path to regain compliance and has stated its intention to do so. A 'hold' recommendation is appropriate given the uncertainty and the company's stated efforts to rectify the situation, pending further developments on their compliance strategy.

Keywords

SES AI, NYSE, Delisting, Listing Standards, Stock Price, Compliance, Form 8-K, Capital Markets